Cotinga Pharmaceuticals Competitors and Similar CompaniesClear all
Cotinga Pharmaceuticals's competitors and similar companies include PACT Pharma and CellmAbs.
 Cotinga Pharmaceuticals Cotinga Pharmaceuticals (formerly Critical Outcome Technologies) is a biopharmaceutical company that specializes in the development of cancer treatments. |  CellmAbs CellmAbs is a biotech company focused on the discovery and development of oncology products, aiming to deliver therapeutic and diagnostic solutions to treat patients with cancer. | ||
Founding Date | Founding Date 2008 | Founding Date 2016 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Toronto, CA HQ Boston, US | Locations South San Francisco, US HQ | Locations Óbidos, PT HQ Lisboa, PT Lisboa, PT |
Employees | Employees N/A | Employees 186% increase | Employees 1 |
Funding | |||
Latest funding round | Latest funding round $ 1.2m (almost 9 years ago) | Latest funding round $ 75m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 4.2m | Total funding raised $ 200m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
PACT Pharma
HQ
South San Francisco, US
Employees
18↑ 6% increase
PACT Pharma operates as a biotechnology company.
View companyCellmAbs
HQ
Óbidos, PT
Employees
1
CellmAbs is a biotech company focused on the discovery and development of oncology products, aiming to deliver therapeutic and diagnostic solutions to treat patients with cancer.
View company